Skip to content

Prospective evaluation of the effect of compound chamomile lidocaine gel on complications in patients undergoing nasal tracheal intubation: A randomized parallel controlled study

Prospective evaluation of the effect of compound chamomile lidocaine gel on complications in patients undergoing nasal tracheal intubation: A randomized parallel controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108092
Enrollment
Unknown
Registered
2025-08-25
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nasopharyngeal complications after nasal intubation

Interventions

Compound chamomile lidocaine gel:Before inserting the tracheal tube, the researchers evenly lubricated the cuff and tip of the tracheal tube with compound chamomile lidocaine gel. After the tube passe
A simple gel formulation without active ingredients:Using the conventional clinical method of lubricating the catheter, the researchers uniformly lubricated the cuff and tip of the tracheal catheter w

Sponsors

West China School/Hospital of Stomatology Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for elective surgery under general anesthesia with nasal tracheal intubation; 2.Patients undergoing bilateral temporomandibular joint disc anchoring surgery under general anesthesia, with a surgery duration of 2-4 hours, aged 18-65 years; 3.American Society of Anesthesiologists (ASA) physical status classification I-II; 4.Body mass index (BMI) 18-27 kg/m^2; 5.Signed informed consent form for the study.

Exclusion criteria

Exclusion criteria: 1.Nasal tumors, such as craniofacial fractures, severe nasal septum deviation or hypertrophy of the nasal conchae, which prevent the passage of the catheter; congenital posterior nasal passage closure; acute craniocerebral injury with increased intracranial pressure; acute sinusitis or nasal infection not controlled; meningitis or intracranial infection; bone marrow transplant patients (nasal flora is prone to cause systemic infections); systemic lupus erythematosus; 2.Respiratory tract obstruction or pharyngeal abscess; 3.Nasal fractures, patients with cranial base fractures and cerebrospinal fluid leakage; 4.Previous history of nasal surgery or trauma; 5.Individuals with drug component allergies; 6.Expected difficult airway; 7.Other individuals not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
The incidence of moderate or severe throat pain within 3 hours after the operation;

Secondary

MeasureTime frame
The incidence of postoperative nasal bleeding;Throat pain score and nasal pain score at 1 hour, 2 hours, 3 hours, 6 hours, and 24 hours after the operation;The success rate of the first intubation;Number of intubations;Other related complications of nasal intubation;;

Countries

China

Contacts

Public ContactJi Yang

West China School/Hospital of Stomatology Sichuan University

yangji7799@163.com+86 136 6626 4254

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026